Researchers at The University of Texas MD Anderson Cancer Center built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most common type of lung cancer. ...
Feb 28, 2024
0
26
The colon is often thought of as one organ, but the right and left parts of the colon have different molecular features in cancers. New research in mice from investigators at the Johns Hopkins Kimmel Cancer Center demonstrates ...
Feb 27, 2024
0
32
Scientists have developed a new screening tool to uncover how genetic changes affect gene activity and can lead to diseases such as cancer, autoimmunity, neurodegeneration and cardiovascular disease. This new tool enables ...
Feb 26, 2024
0
17
Europe's medicines watchdog gave the green light Friday to a new treatment for a rare form of the neurodegenerative disease ALS, saying it should reduce the symptoms of the deadly illness.
Feb 23, 2024
0
1
A recent study has discovered a biological role of a specific transmembrane protein called TMEM208. The research, published in the Proceedings of the National Academy of Sciences, showed that a majority of fruit flies lacking ...
Feb 23, 2024
0
27
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself.
Feb 7, 2024
0
148
Epithelioid sarcoma, a rare aggressive cancer that usually strikes young adults, and rhabdoid tumors, which affect children, have long been difficult to treat. But the outlook for people with these subtypes of soft tissue ...
Feb 5, 2024
0
9
Scientists have made an unusual discovery that could help to identify patients who are up to two-and-a-half times more likely to respond to currently available cancer drugs.
Jan 29, 2024
0
91
Biomedical engineers at Duke University have demonstrated that one of the most dangerous mutations found in skin cancers might moonlight as a pathway to mending a broken heart.
Jan 24, 2024
0
55
A new study has found a molecule hailed as a potential drug candidate for Parkinson's disease is no longer an effective therapeutic option. The WEHI-led research has debunked over 10 years of research that suggested a specific ...
Jan 22, 2024
0
24
